Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

2,357 recalls · Class II, newest first

Class II · Moderate risk

Hand Sanitizer

CGMP Deviations: Voluntary recall of all hand sanitizer distributed after March 31, 2022, due to FDA issued guidance to cease placing hand sanitizer product, produced under temporary approval, into the market after March 31, 2022.

Ongoing cGMP deviation Fisher Scientific Co., LLC D-0163-2023
Class II · Moderate risk

Humatrix Microclysmic Gel

CGMP Deviations: initiated due to violations of CGMP manufacturing practices

Ongoing cGMP deviation Consolidated Chemical, Inc D-0326-2023
Class II · Moderate risk

0.9% Sodium Chloride Injection

Lack of Assurance of Sterility: Leakage of 0.9% Sodium Chloride for Injection, 1L, 12pk Saline Solution.

Ongoing Sterility / contamination Fresenius Medical Care Holdings, Inc. NDC 49230-300-10 D-0075-2023
Class II · Moderate risk

Daytrana (methylphenidate transdermal system)

Defective Delivery System: Recalled lot was found to be out of specification for shear. Shear is an attribute related to the adhesive properties of the transdermal patches.

Ongoing Packaging defect Noven Pharmaceuticals Inc NDC 68968-5553-3 D-0071-2023
Class II · Moderate risk

Adam's Polishes ALCOHOL BASED HAND SANITIZER

CGMP Deviations: Other lots of hand sanitizer are being recalled because they were manufactured under the same conditions as the product lot found to contain methanol.

Ongoing Chemical / undeclared Adam's Polishes LLC NDC 74943-125-04 D-0067-2023

Recalls by year